AGEN

Neutral

[ARS] AGENUS INC SEC Filing

This article reports on an ARS SEC filing by Agenus Inc. (AGEN) on April 30, 2026, noting a neutral sentiment and low impact. It provides an overview ...

Stock Titan 1 week ago 0

Bullish

Agenus Names BAP Pharma as Exclusive Global Partner for BOT+BAL Access Programs

Agenus Inc. has partnered exclusively with BAP Pharma to manage global access programs for its botensilimab (BOT) plus balstilimab (BAL) therapies. Th...

뉴스와이어 2 weeks ago 0